# Chemoprevention Study of Oral Cavity Squamous Cell Carcinoma

> **NCT00201279** · PHASE3 · COMPLETED · sponsor: **National Health Research Institutes, Taiwan** · enrollment: 342 (—)

## Conditions studied

- Oral Cavity
- Squamous Cell Carcinoma

## Interventions

- **DRUG:** 13-cis Retino Acid

## Key facts

- **NCT ID:** NCT00201279
- **Lead sponsor:** National Health Research Institutes, Taiwan
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-04
- **Primary completion:** —
- **Final completion:** 2012-09
- **Target enrollment:** 342 (—)
- **Last updated:** 2005-09-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00201279

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00201279, "Chemoprevention Study of Oral Cavity Squamous Cell Carcinoma". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00201279. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*